Start Your NewsReadery Pro FREE TRIAL!

Register and verify your email address to start your NewsReadery Pro FREE TRIAL today!

Login / Register

seekingalpha.com / Share Newsitem

View, share or embed this newsitem using the details below.
EyePoint Pharmaceuticals, Inc. (EYPT) announces pricing of public offering, expected to raise $140.0 million for innovative retinal disease therapeutics.
Continue
Please wait ...